Trial Outcomes & Findings for Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery (NCT NCT01099475)

NCT ID: NCT01099475

Last Updated: 2014-10-17

Results Overview

At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by L-FABP) level. These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3. This continuous variable with repeated measurements was summarized as area under the curve (AUC) from baseline to postoperative day 3 (as described in Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Bmj 1990;300:230-5).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

L-FABP area under curve from start of surgery up until postoperative day 3

Results posted on

2014-10-17

Participant Flow

Inclusion of participants: Oct 2007 - Jul 2009 Location: Department of Surgery, Maastricht University Medical Centre

Participant milestones

Participant milestones
Measure
Pringle Manoeuvre Using 15 Minutes Inflow Occlusion
When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion. Pringle manoeuvre using 15 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
Pringle Manoeuvre Using 30 Minutes Inflow Occlusion
When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion Pringle Manoeuvre using 30 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
Overall Study
STARTED
10
10
Overall Study
COMPLETED
10
10
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Pringle Manoeuvre Using 15 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion. Pringle manoeuvre using 15 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
Pringle Manoeuvre Using 30 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion Pringle Manoeuvre using 30 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
Total
n=20 Participants
Total of all reporting groups
Age, Continuous
64 years
n=5 Participants
62 years
n=7 Participants
62 years
n=5 Participants
Sex: Female, Male
Female
4 Participants
n=5 Participants
4 Participants
n=7 Participants
8 Participants
n=5 Participants
Sex: Female, Male
Male
6 Participants
n=5 Participants
6 Participants
n=7 Participants
12 Participants
n=5 Participants
Region of Enrollment
Netherlands
10 participants
n=5 Participants
10 participants
n=7 Participants
20 participants
n=5 Participants
American Society of Anesthesiologists (ASA) classification
ASA 1
0 participants
n=5 Participants
2 participants
n=7 Participants
2 participants
n=5 Participants
American Society of Anesthesiologists (ASA) classification
ASA 2
8 participants
n=5 Participants
5 participants
n=7 Participants
13 participants
n=5 Participants
American Society of Anesthesiologists (ASA) classification
ASA 3
2 participants
n=5 Participants
3 participants
n=7 Participants
5 participants
n=5 Participants
Indication for resection
benign disease
0 participants
n=5 Participants
1 participants
n=7 Participants
1 participants
n=5 Participants
Indication for resection
malignant disease
10 participants
n=5 Participants
9 participants
n=7 Participants
19 participants
n=5 Participants

PRIMARY outcome

Timeframe: L-FABP area under curve from start of surgery up until postoperative day 3

At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by L-FABP) level. These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3. This continuous variable with repeated measurements was summarized as area under the curve (AUC) from baseline to postoperative day 3 (as described in Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Bmj 1990;300:230-5).

Outcome measures

Outcome measures
Measure
Pringle Manoeuvre Using 15 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion. Pringle manoeuvre using 15 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
Pringle Manoeuvre Using 30 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion Pringle Manoeuvre using 30 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
Hepatocellular Damage Reflected by Liver Fatty-acid Binding Protein (L-FABP) Levels
9097 ng*h/mL
Standard Error 1781
11,688 ng*h/mL
Standard Error 2247

SECONDARY outcome

Timeframe: within 90-days after initial liver surgery

morbidity and mortality occuring after liver surgery graded according to Clavien-Dindo's grading system. In short, any deviation from the postoperative course without the need for pharmacological, radiological or surgical intervention was classified as Clavien-Dindo grade 1; complications requiring pharmacological treatment were graded as grade 2; complications requiring surgical or radiological intervention not under general anesthesia as grade 3a and under general anesthesia as grade 3b; grade 4 complications were life-threatening complications requiring intensive care unit care because of single organ dysfunction (grade 4a) or multiple organ dysfunction (grade 4b); mortality was classed as grade 5.

Outcome measures

Outcome measures
Measure
Pringle Manoeuvre Using 15 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion. Pringle manoeuvre using 15 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
Pringle Manoeuvre Using 30 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion Pringle Manoeuvre using 30 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
Post-resectional Complications
intra-abdominal abscess
3 participants
2 participants
Post-resectional Complications
intra-abdominal hemorrhage
0 participants
1 participants
Post-resectional Complications
bile leakage
4 participants
1 participants
Post-resectional Complications
ascites
1 participants
0 participants
Post-resectional Complications
sepsis
1 participants
2 participants
Post-resectional Complications
post-resectional liver failure
2 participants
1 participants
Post-resectional Complications
30-day mortality
1 participants
1 participants

SECONDARY outcome

Timeframe: at the end of liver surgery, an average of 225 minutes

amount of blood in the suction container (and, if applicable, in the weighted gauzes)

Outcome measures

Outcome measures
Measure
Pringle Manoeuvre Using 15 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion. Pringle manoeuvre using 15 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
Pringle Manoeuvre Using 30 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion Pringle Manoeuvre using 30 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
Amount of Blood Loss
575 mL
Interval 100.0 to 2300.0
450 mL
Interval 250.0 to 1000.0

SECONDARY outcome

Timeframe: ALAT area under curve from start of surgery up until postoperative day 3

At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by ALAT level. These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3.

Outcome measures

Outcome measures
Measure
Pringle Manoeuvre Using 15 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion. Pringle manoeuvre using 15 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
Pringle Manoeuvre Using 30 Minutes Inflow Occlusion
n=10 Participants
When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion Pringle Manoeuvre using 30 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
Hepatocellular Damage Reflected by Alanine Aminotransferase (ALAT) Levels
3196 IU*h/L
Standard Error 797
3609 IU*h/L
Standard Error 812

Adverse Events

Pringle Manoeuvre Using 15 Minutes Inflow Occlusion

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Pringle Manoeuvre Using 30 Minutes Inflow Occlusion

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. MAJ van den Broek, MD

Maastricht University Medical Centre

Phone: 31 43 3884502

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place